Faces Of Digital Health

Dr. Marinka Žitnik is a computer scientist from Harvard, studying applied machine learning with a focus on challenges brought forward by data in science, medicine, and health. A large aspect of her work concerns the use of AI for better use of medications - either by analyzing and predicting side effects in polypharmacy or by potentially discovering new indications of combinations of drugs that are already on the market. Dr. Zitnik joined Harvard as an Assistant Professor in December 2019. Before that, she was a postdoctoral scholar in Computer Science at Stanford University. She was also a member of the Chan Zuckerberg Biohub at Stanford. Some of her methods are used by major biomedical institutions, including Baylor College of Medicine, Karolinska Institute, Stanford Medical School, and Massachusetts General Hospital. In this discussion, she talks about the role of AI in the development of COVID vaccines, the role of AI in drug development, realistic expectations of AI tools we can expect in the next 5 to

According to WHO the occurrence of adverse events due to unsafe care is likely one of the 10 leading causes of death and disability in the world.  Patient harm is caused by several healthcare issues.  Healthcare-associated infections occur in 7 and 10 out of every 100 hospitalized patients in high-income countries and low- and middle-income countries respectively (11). Unsafe surgical care procedures cause complications in up to 25% of patients. Patient harm is caused by unsafe injections practices in health care settings, unsafe transfusion practices, diagnostic errors, radiation errors, sepsis is frequently not diagnosed early enough, Venous thromboembolism (blood clots) is one of the most common and preventable causes of patient harm. On top of the list are medication errors. Medication errors are a leading cause of injury and avoidable harm in health care systems: globally, the cost associated with medication errors has been estimated at US$ 42 billion annually. Abdulelah Alhawsawi is the Ex - founding Di

Lea Dias is a former Medication Safety Pharmacist at Perth Children’s Hospital, now the Founder and CEO of Quaefacta. In 2013, the Winston Churchill Memorial Trust enabled her to go on a six-week tour around the world, to visit several hospitals in the US, UK, and Israel, and assess how various institutions used technologies for patient safety improvement. Three years later, she went on another tour to get additional insights from hospitals in Bulgaria, France, Spain, UK, Singapore and Thailand. She brought the knowledge back to Australia, where she led the implementation of a pharmacy robotics system. In this discussion, we talked about medication errors she saw in her clinical practice, the causes of those errors, and what were her takeaways from the two world tours related to patient safety. Today, Lea is using all that knowledge to build her company Quafecta, which aims to empower patients to make informed healthcare decisions via ownership of their own health data.  !!For Medical Doctors in the USA: Bas

Some say fax machines still exist because of healthcare. Across the world, paper is still heavily used in healthcare. The NHS is on course to eliminate paper prescribing in hospitals and introduce digital prescribing across the entire NHS by 2024. From 2018 until the end of 2020, 216 NHS trusts have received funding to implement systems electronic prescriptions and medicines administration (ePMA).  IT implementations in healthcare take several months. Clinicians need to use several systems, learn about updates of the system. Sometimes digitalization requires more time for documenting patient care. Therefore clinicians can be disappointed that most digital solutions at the moment aren’t high-tech decision support systems that would take away the cognitive load from clinicians. Digital systems still require clinicians to basically not expect the systems to think instead of them. In this discussion you will hear from Duncan Cripps - Electronic Prescribing and Medication Management Lead at University Hospitals P

Do you know what clinical pharmacists do? For one thing, clinical pharmacists optimize patient’s medications. This can have a big impact on improving patient outcomes and patient quality of life. In today’s discussion, you’re going to hear from Dr. John Horn, Emeritus Professor of Pharmacy and Associate Director of the UW Medicine Pharmacy Services. He is co-author of the reference texts Drug Interactions Analysis and Management and The Top 100 Drug Interactions: A Guide to Patient Management. In addition to over 250 publications related to drug interactions, Dr. Horn has published in the areas of cardiovascular and gastrointestinal therapeutics and pharmacokinetics. You will hear: why are pharmacists integral team members in patient care, why is medication adherence in patients impossible to reach, dr Horn also shared his thoughts about the potential and near future of 3D printing. Teaser: he is very skeptical about seeing that work in practice. This interview was conducted for the purpose of the movie OVE

Being a doctor can be very gratifying when a life is saved or a patient is cured. However, the number of jobs and skills physicians need to master is increasing with the advancement of technology and science. This makes the medical environment increasingly stressful, also because at the moment, many IT solutions are burdensome and add the bureaucratic workload to the schedules of doctors. Today’s topic is how to doctors approach and manage medication prescribing. I spoke with David W. Bates, Patient Safety Expert and Harvard MD, who is an internationally renowned expert in patient safety, using information technology to improve care, quality-of-care, cost-effectiveness, and outcomes assessment in medical practice. He is a Professor of Medicine at Harvard Medical School, and a Professor of Health Policy and Management at the Harvard School of Public Health, where he co-directs the Program in Clinical Effectiveness. He directs the Center for Patient Safety Research and Practice at Brigham and Women’s Hospital,

Nurses are the backbone of healthcare. They’re the closest to the patient, they offer support to them and the doctors. Their mission is to make patients feel better and recover as fast as possible. There is a global shortage of nurses and more often than not, nurses are stretched thin. The same as with doctors, mistakes can happen in nursing. You are going to hear from Martina Viduka A practicing nurse and the CEO of Advosense. In this discussion, she presented the nursing perspective on medication management in the hospital setting. This interview was part of the discussions recorded for the movie (OVER)DOSE - How can we prevent medication errors?. Find the link to the movie in the show notes, and see or hear the interviews with other speakers as well. I spoke with 10 experts from six countries across the world to understand why is medication-related patient safety a global problem in which everyone plays a role - the patient and his family, the doctors, the nurses, and the pharmacists. Watch the documentar

With mental health being at the forefront of our attention in 2020, next to COVID, have you ever wondered, how the work of a psychiatrist looks like? Many clinicians fear psychiatric drugs, but Roni Shiloh firmly believes the fear is unnecessary.  Roni Shiloh is an MD, specialized in psychiatry. He headed a closed Psychiatric Department, was Chief Psychiatric Officer at a large Israeli HMO as well a senior lecturer in Tel-Aviv University, Israel. He then worked in the Pharmaceutical industry before starting his own startup Seegnal, which offers clinicians decision support in medication prescribing. The system takes into account many of a patient’s variables to be as accurate as possible, and more importantly, for the decision support to not overwhelm the doctor with alerts. Electronic prescribing and medication management are very complex and plagued with errors, which I tried to outline in the documentary OVERDOSE - How can we prevent medication errors. If you haven’t seen the movie yet, find the link in th

This is a panel discussion that happened after the premiere of the documentary (OVER)DOSE - How can we prevent medication errors? which aired on 29 June. You can listen to the adapted audio-only version of the documentary in episode 137. The documentary explores and offers an overview of the current challenges and technical solutions related to medication safety to raise awareness about the need to further improve medication-related patient safety.  Unsafe medication practices and medication errors are a leading cause of injury and avoidable harm in health care systems across the world. Globally, the cost associated with medication errors has been estimated at $42 billion USD annually. Errors can occur at different stages of the medication use process. More than 237 million medication errors are made every year in England, the avoidable consequences of which cost the NHS upwards of £98 million and more than 1700 lives every year, indicate national estimates, published online in the journal BMJ Quality & Safet

This is a short documentary about medication-related patient safety. The documentary explores and offers an overview of the current challenges and technical solutions related to medication safety to raise awareness about the need to further improve medication-related patient safety.  Unsafe medication practices and medication errors are a leading cause of injury and avoidable harm in health care systems across the world. Globally, the cost associated with medication errors has been estimated at $42 billion USD annually. Errors can occur at different stages of the medication use process. More than 237 million medication errors are made every year in England, the avoidable consequences of which cost the NHS upwards of £98 million and more than 1700 lives every year, indicate national estimates, published online in the journal BMJ Quality & Safety.  The documentary premiered on 29 June and was accompanied by an expert panel discussion which you can listen to in episode 138. Watch the documentary: https://www.f

David Kliff is the author and publisher of the Diabetic Investor eNewsletter, former investment advisor and as a person living with diabetes. As the author and publisher of the Diabetic Investor eNewsletter, David Kliff has spent the last 20 years analyzing the ups and downs of the diabetes industry. He closely monitors the diabetes biomed, biotech and device market and shares intel on breaking developments in existing and emerging pharmaceutical and tech companies that operate in that space.  In this episode, David talks about improvements in diabetes care and the psychological impacts and challenges contributing to low adherence to medication adherence and other diabetes treatment-related challenges. This discussion was recorded as part of the research for the documentary (OVER)DOSE - How can we prevent medication errors?  Join the premiere on 29 June: https://www.linkedin.com/events/over-dose-howcanwepreventmedica6800062280823263232/ More details about the event: https://www.facesofdigitalhealth.com/blog/o

Because US healthcare is private and operates by the rules of the free market, prices for services and medications can differ substantially. Solutions such as GoodRx and Amazon Pharmacy are addressing price transparency for consumers. On the other side are the Real Time Prescription Benefit Providers which help physicians see drug prices for a specific patient even before that patient leaves their office. The challenge with knowing how much a drug will cost a patient lies in the fact that different insurance companies have different policies regarding how much they will pay for medication. Patients might have a plan with high deductibles. But it’s not just the provider and the insurance company: prices depend on the Pharmacy Benefit Managers (PMS) - intermediaries that manage prescription drug benefits on behalf of health insurers. PBMs negotiate prices with drug manufacturers and pharmacies.  In this episode, Carm Huntress, the CEO of RxRevu Real Time Prescription Benefit Provider company, talks about the u

Funding in technologies, especially software in healthcare, has been booming in the last few years. Recently, SPACs - special purpose acquisition companies have gained in popularity. SPACs are not a new vehicle that makes it much easier for companies to go public. But it seems like their use has been reborn in the last year. This episode is prepared in partnership with mHealth Israel. mHealth Israel, led by Levi Shapiro, recently organized a webinar about SPACs. That webinar is adapted for audio in this episode.  This is a three-part episode. First, you’re going to hear about what SPACs are as explained by Keith Townsend from the law firm King & Spalding. Then Sari Kaganoff, General Manager at Rock Health will take you through the state of SPACs in healthcare. The two presentations are followed by a Q&A session. The whole content is moderated by Gil Bashe, digital health thought leader and Managing Partner at Finn Partners marketing agency.  Watch the SPAC webinar on Youtube: https://www.youtube.com/watch?v

Simone Lehwess Mozzilli and Liliane Dübois both had cancer in their past. Liliane as a child, Simone as an adult. They are both an integral part of the Brazilian non-profit Beaba. Beaba offers support to children with cancer and their families by demystifying cancer and informing in a clear, objective, and optimistic way about the disease and treatment. They do so through various means, for example, a printed book called Beabook which resembles a dictionary and explains more than one hundred and fifty terms about cancer. In this episode, Simone, who is the President of Beaba, and Liliane, who is the Strategy Officer, talked about how to approach children with cancer, what they’ve learned from the app and other products being used across the world and talked a little bit about cancer care in Brazil.  Join the premiere of (OVER)DOSE - How can we prevent medication errors? More info: https://www.facesofdigitalhealth.com/blog/overdose-how-can-we-prevent-medication-errors  Go to www.facesofdigitalhealth.com to bro

Unsafe medication practices and medication errors are a leading cause of injury and avoidable harm in health care systems across the world. Globally, the cost associated with medication errors has been estimated at $42 billion USD annually. Errors can occur at different stages of the medication use process. This is the movie trailer, adopted for audio for a short documentary (OVER)DOSE, How can we prevent medication errors? which will air on 29 June 2021. More about the event: https://www.linkedin.com/events/over-dose-howcanwepreventmedica6800062280823263232/  Video trailer: https://www.youtube.com/watch?v=cPKvDYSm1mI&t=29s  Speakers in this episode:  David Kliff has been living with diabetes for over 20 years. He’s known as the Diabetic Investor, which is the name of the newsletter he’s been publishing for over two decades. Dr. David W. Bates, Professor of Health Policy and Management at Harvard T.H. Chan School of Public Health. Lea Dias is the founder of a healthcare startup called Quaefacta. She is a

Phishing, Whaling, and exposure of patient data are a rising occurrence of the increasingly digitalized healthcare systems. 2020 saw more data breaches than previous years. What are the basics to know? Lee Kim is Director of Privacy and Security at HIMSS. In this episode, she talks about the basics of cybersecurity every individual should know, she presents the state of cybersecurity in healthcare and the outlook. Episode Summary: www.facesofdigitalhealth.com/blog/f132-whats-the-state-of-cybersecurity-in-healthcare-lee-kim See the video interview on Youtube: https://www.youtube.com/watch?v=kv1SM38siyo&t=25s Thanks to our Sponsor: Health Resources and Services Administration: Receive up to $250,000 in student loan repayment in exchange for service in a community disproportionately affected by the opioid crisis. Learn more and apply to join STAR LRP - that stands for the Substance Use Disorder Treatment and Recovery Loan Repayment Program. Applications Close on July 22, 2021

How would you rate your pain on a scale of 1 to 10? Pain is a very subjective matter and there’s plenty of research done and in progress to understand it better. In this episode Sara E. Berger, a researcher at IBM with over a decade of experience in the pain field talks about how science defines pain in the first place, how can pain be quantified given the variety of factors that impact it, and how does the research so far translate into clinical practice.  Thanks for our Sponsor: Health Resources and Services Administration: Receive up to $250,000 in student loan repayment in exchange for service in a community disproportionately affected by the opioid crisis. Learn more and apply to join STAR LRP - that stands for the Substance Use Disorder Treatment and Recovery Loan Repayment Program. Applications Close on July 22, 2021 To read more about other topics as well go to www.facesofdigitalhealth.com. Faces of digital health is now also live on the Youtube channel: https://www.youtube.com/channel/UCEOzIOl_wI

It is absolutely scary to get an infection and run out of options to treat it. Broadly speaking, existing antibiotics are and are going to keep losing their effectiveness, if antibiotics and antimicrobials are not used effectively. In this episode, you will hear a discussion with Mr. Oliver Schacht, a corporate finance professional and expert in the molecular diagnostics industry. He is the CEO of OpGen which developed cloud-based software to identify, track and predict antibiotic-resistant infections. In this episode, he talks about the factors impacting the global issue of antimicrobial resistance, the role of rapid diagnostics in the process of effective prescribing of antibiotics, and also the political and economic factors impacting the development of antibiotics. Enjoy the show, and if you’ll like what you hear, subscribe to be notified about new episodes automatically. And if you prefer podcasts, find Faces of digital health where ever you listen to podcasts.   OpGen: https://www.opgen.com/ Episode rec

Bianca Rose Phillips is a Global Digital Health Law theorist from Australia, and the founder of a Digital Health Think Tank. In her legal work, she is focused mostly on Australia and the USA. Many people know her by her framework of the so-called 8 pillars of digital health law-making. Bianca also contributed to the recently published book, Voice Technology in Healthcare, she is a lecturer and she also runs two podcasts - Too nice for law and Digital Health Law series. In this discussion, she talks about the current state of digital health law in general, why she opted out of My Health Record, why patients need to be responsible about their data, the legal standpoints in data privacy and ownership, and more. Episode Summary More about Bianca:  Website: www.biancarosephillips.com LinkedIn: https://www.linkedin.com/in/biancaphillips/ Join the Voice for equality event on 28 April Browse through other episodes as well at www.facesofdigitalhealth.com

Casey Ross is an investigative reporter for STAT News, where he covers AI development in healthcare and medicine. Last year he analyzed over 160 AI product market approval submissions cleared by the FDA between 2012 and 2020. As it turns out criteria for assessment and the dataset submitted differed a lot. Only 7 of 161 AI products cleared by the FDA in recent years, included any information about the racial composition of their datasets. Those devices were cleared to use AI for the diagnosis of a wide array of serious conditions, including heart disease, strokes, and respiratory illnesses. In this discussion, Casey talks about the state of trust in AI solutions in healthcare, what have we learned from the development of IBM Watson, and more. Enjoy the discussion, which you can also listen to wherever you get your podcasts. And if you’d like to see other topics and episodes as well, do go to www.facesofdigitalhealth.com. Episode Summary